Drug Injury Watch

Side Effects News & Reports

From 2005 to the present

Current Evidence Of Associations Between Hormone-Replacement Therapy Drugs And Several Serious Side Effects

Drug Safety Update Publishes September 2007 Guide For Doctors To Assess HRT Risks And Benefits

(Posted by Tom Lamb at DrugInjuryWatch.com)

The second issue of Drug Safety Update, an electronic bulletin (PDF file) published by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), was published on September 3, 2007. It includes some important side effects information for doctors who prescribe hormone-replacement therapy (HRT).

As described by Claire Tilstone, the Editor of Drug Safety Update: 

We have prepared digested guide of current evidence for the associations between HRT and coronary heart disease; stroke; venous thromboembolism; and cancers of the breast, endometrium, or ovary. We hope that this updated information, including
revised risk estimates, will help healthcare professionals assess the risks and
benefits associated with HRT for individual women.

Of course, this advisory article from Volume 1, Issue 2 of Drug Safety Update will also be of interest to some of the women who use HRT drugs as well as others who follow the developing safety profile of HRT drugs.

2 responses to “Current Evidence Of Associations Between Hormone-Replacement Therapy Drugs And Several Serious Side Effects”

  1. Aubrey Blumsohn Avatar
    Aubrey Blumsohn

    Thank you for this Tom
    Speaking from the UK, it is probably advisable to inform readers that “Drug Safety Update” is a product of the thouroughly discredited and unreformed UK drug regulator (See HoC Select Committee report of 2004 [1]. It claims to bring “information and clinical advice from the MHRA and the Commission on Human Medicines, its independent advisor, about the safe use of medicines”.
    Unfortunately a truly independent bulletin with a somewhat similar name (Drug and Therapeutics Bulletin) had its funding withdrawn by the government without any consultation [2] presumably
    as a result of various meetings [3] which took place between government officials and pharmaceutical CEO’s. This may be designed to give the appearance of filling that partial “independent information” niche.
    This would therefore not be derived from a credible source (though this is not to say that everything they do is incredible – but not far off).
    1. http://scientific-misconduct.blogspot.com/2006/07/mhra-why-is-government-not-acting.html
    2. Hansard at: http://www.theyworkforyou.com/wrans/?id=2006-06-14a.75477.h
    3. http://scientific-misconduct.blogspot.com/2006/09/this-is-what-we-are-up-against-fall-of.html

    Reply
  2. Tom Lamb Avatar
    Tom Lamb

    Aubrey:
    Thanks for your keen insight from the UK on this situation concering “Drug Safety Update”.
    Keep up the good work over there.
    To those reading, I commend you to visit regularly the “Scientific Misconduct” web site, published by Aubrey Blumsohn. It is listed under the heading SITES TO SEE in the sidebar. You can start with the posts listed by Aubrey in his comment, above.

    Reply

Leave a Reply to Aubrey Blumsohn Cancel reply

Your email address will not be published. Required fields are marked *